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Background
The geno2pheno algorithm (g2p) can give dichotomous
tropism based on a selectable “false positive rate” (FPR),
reflecting the proportion of individuals inappropriately
called “non-R5” and falsely excluded from taking CCR5
antagonists. The effect of replicate genotype measures
and different FPR values remains controversial. Here we
characterize different FPR “cut-points” in predicting
tropism for single vs multiple replicates for interpreting
V3 genotype based on data from the clinical trials of
Maraviroc (MVC) in experienced patients.
Methods
The first study population comprised all patients
screened for MOTIVATE 1 (N=1399; 44% non-R5 by
original Trofile) for whom both triplicate and single V3
genotypes were available. We also examined virological
response (defined as a week 8 decrease ≥2l o g sa n d / o r
to <50 copies/ml) in an outcome dataset of 547 patients
who received MVC+optimizedb a c k g r o u n dt h e r a p yi n
the MOTIVATE-1, 2 or A4001029 studies with very
limited background antiviral activity from other agents
(wSS <1).
Results
Triplicate sequence analyses typically identified 10-25%
more individuals with non-R5 virus compared to single
replicates. A comparison of the predicted FPR by g2p to
the virologically defined FPR at different g2p cut-points
showed an excellent correlation (r2 =0.99; see Table 1),
but appeared to be calibrated conservatively (slope =1.5
for single assays or 1.7 for triplicate assays). Some of
this miscalibration likely reflects a contribution from
background therapies. For comparison, the FPR of Tro-
file in this population was 3.9% (N=49 DM patients).
Conclusions
The g2P algorithm shows the expected association with
observed virological response, but this testing proce-
dure may be more conservative than expected from
the nominal FPR values, particularly for triplicate
sequence analysis. A g2p FPR value above 10 likely BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
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Table 1
MOTIVATE-1 Screening
(N=1399)
Virological Outcome Set
(N=547)
G2p
FPR
Number non-Rf Number Non-Rf Actual FPR
(single) (triplicate) (single) (triplicate) (single) (triplicate)
1 100 114 6 9 0.6 0.6
2 241 288 25 36 1.3 1.3
3 303 368 39 47 2.3 2.6
4 362 427 48 57 3.6 4.2
5 396 459 52 64 4.5 5.2
5.75 423 486 57 71 6.1 7.4
6 433 496 62 77 6.8 8.4
7 476 533 71 89 8.4 10.0
8 507 563 78 98 9.7 11.7
9 548 605 88 114 12.0 13.9
10 562 620 89 116 12.3 13.9
15 646 715 132 161 21.4 23.6
20 742 805 174 205 28.5 32.4
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therapy if this cut-off is employed to screen individuals
for maraviroc.
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